Bone marrow cells produce soluble factors that inhibit osteoclast activity

Journal of Orthopaedic Research

Volumn 17, Issue 1, 1999, Pages 51-58

  Ninomiya, J T ^a   Bi, Y ^a   Banks, M A ^a   Lavish, S A ^a   Goldberg, V M ^a   Greenfield, E M ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CELL CULTURE; DISEASES; HORMONES; IMPLANTS (SURGICAL); ORTHOPEDICS; PHYSIOLOGY;

CYTOKINES;

BONE;

INTERLEUKIN 1; INTERLEUKIN 6; PARATHYROID HORMONE DERIVATIVE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CELL FATE; CELL SPECIFICITY; CYTOKINE PRODUCTION; GROWTH INHIBITION; GROWTH REGULATION; HORMONAL REGULATION; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; RAT;

EID: 0033006313     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.1100170109     Document Type: Article

References (78)

1. 1 Algan SM, Purdon M, Horowitz SM: Role of tumor necrosis factor alpha in particulate‐induced bone resorption. J Orthop Res 14: 30–35, 1996
2. 2 Ammann P., Rizzoli R, Bonjour JP, Bourrin S., Meyer JM, Vassalli P., Garcia I: Transgenic mice expressing soluble tumor necrosis factor‐receptor are protected against bone loss caused by estrogen deficiency. J Clin Invest 99: 1699–1703, 1997
3. 3 Arend WP: Interleukin‐1 receptor antagonist. Adv Immunol 54: 167–227, 1993
4. 4 Bellido T, Jilka RL, Boyce BF, Girasole G, Broxmeyer H, Dalrymple SA, Murray R, Manolagas SC: Regulation of interleukin‐6, osteoclastogenesis, and bone mass by androgens:the role of the androgen receptor. J Clin Invest 95: 2886–2895, 1995
5. 5 Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS: Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen‐responsive cells in culture. Proc Natl Acad Sci U S A 83: 2496–2500, 1986
6. 6 Bi Y, Ragab AA, Goldberg VM, Greenfield EM: Titanium wear particles stimulate osteoclast differentiation in vitro. Trans Orthop Res Soc 23: 283, 1998
7. 7 Bizzarri C, Shioi A, Teitelbaum SL, Ohara J, Harwalkar VA, Erdmann JM, Lacey DL, Civitelli R: Interleukin‐4 inhibits bone resorption and acutely increases cytosolic Ca2+ in murine osteoclasts. J Biol Chem 269: 13817–13824, 1994
8. 8 Burkhart JM, Jowsey J: Parathyroid and thyroid hormones in the development of immobilization osteoporosis. Endocrinology 81: 1053–1062, 1967
9. 9 Cohen‐Solal ME, Graulet AM, Denne MA, Gueris J, Baylink D, de Vernejoul MC: Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: involvement of cytokines. J Clin Endocrinol Metab 77: 1648–1653, 1993
10. 10 Dieudonne SC, Foo P, Van zoelen EJJ, Burger EH: Inhibiting and stimulating effects of TGF‐b1 on osteoclastic bone resorption in fetal mouse bone organ cultures. J Bone Miner Res 6: 479–487, 1991
11. 11 Frisch RE, Canick JA, Tulchinsky D: Human fatty marrow aromatizes androgen to estrogen. J Clin Endocrinol Metab 51: 394–396, 1980
12. 12 Fuller K, Owens JM, Chambers TJ: Macrophage inflammatory protein‐1 alpha and IL‐8 stimulate the motility but suppress the resorption of isolated rat osteoclasts. J Immunol 154: 6065–6072, 1995
13. 13 Glant TT, Jacobs JJ, Molnar G, Shanbhag AS, Valyon M, Galante JO: Bone resorption activity of particulate‐stimulated macrophages. J Bone Miner Res 8: 1071–1079, 1993
14. 14 Glant TT, Jacobs JJ: Response of three murine macrophage populations to particulate debris: bone resorption in organ cultures. J Orthop Res 12: 720–731, 1994
15. 15 Glowacki J: Influence of age on human marrow. Calcif Tissue Int 56 (Suppl 1): 50–51, 1995
16. 16 Greenfield E, Lavish S, Ragab A: Mesenchymal cells promote osteoclast differentiation by producing both cell surface and extracellular matrix molecules. J Bone Miner Res 11 (Suppl 1): 283, 1996
17. 17 Greenfield EM, Gornik SA, Horowitz MC, Donahue HJ, Shaw SM: Regulation of cytokine expression in osteoblasts by parathyroid hormone: rapid stimulation of interleukin‐6 and leukemia inhibitory factor mRNA. J Bone Miner Res 8: 1163–1171, 1993
18. 18 Greenfield EM, Shaw SM, Gornik SA, Banks MA: Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption. J Clin Invest 96: 1238–1244, 1995
19. 19 Greenfield EM: The role of interleukin‐6 in stimulation of osteoclast differentiation and activity by neuropeptides and other bone resorptive agents. In: Biological Mechanisms of Tooth Movement and Craniofacial Adaptation, Proceedings of the Second International Conference Held at Tara's Ferncroft Conference Resort, Danvers, Massachusetts, October 19‐22, 1995, pp 301–307. Ed by Z Davidovtch and LA Norton Birmingham, Harvard Society for the Advancement of Orthodontics, 1996
20. 20 Greenfield EM, Horowitz MC, Lavish SA: Stimulation by parathyroid hormone of interleukin‐6 and leukemia inhibitory factor expression in osteoblasts is an immediate‐early gene response induced by cAMP signal transduction. J Biol Chem 271: 10984–10989, 1996
21. 21 Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimdal PL, Armes LG, Sommer A, Eisenberg SP, Thompson RC: Interleukin‐1 receptor antagonist activity of a human interleukin‐1 inhibitor. Nature 343: 336–340, 1990
22. 22 Hansen MB, Nielsen SE, Berg K: Re‐examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119: 203–210, 1989
23. 23 Hattersley GJ, Chambers TJ: Effects of interleukin 3 and of granulocyte‐macrophage and macrophage colony stimulating factors on osteoclast differentiation from mouse hemopoietic tissue. J Cell Physiol 142: 201–209, 1990
24. 24 Heaney RP, Recker RR, Saville PD: Menopausal changes in bone remodeling. J Lab Clin Med 92: 964–970, 1978
25. 25 Herman JH, Sowder, WG, Anderson, D, Appel, Am, Hopson CN: Polymethylmethacrylate‐induced release of boneresorbing factors. J Bone Joint Surg [Am] 71: 1530–1541, 1989
26. 26 Horowitz MC: Cytokines and estrogen in bone: anti‐osteoporotic effects. Science 260: 626–627, 1993
27. 27 Howie DW, Haynes DR, Rogers SD, McGee MA, Pearcy MJ: The response to particulate debris. Orthop Clin North Am 24: 571–581, 1993
28. 28 Hsu JC, Bukata SV. Lewis GD. Hicks DG. Puzas JE, O'Keefe RJ: Paracrine induction of IL‐10 in periprosthetic osteolysis. Trans Orthop Res Soc 23: 125, 1998
29. 29 Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC: Increased osteoclast development after estrogen loss: mediation by interleukin‐6. Science 257: 88–91, 1992
30. 30 John V, Hock JM, Short LL, Glasebrook AL, Galvin RJ: A role for CD8+ T lymphocytes in osteoclast differentiation in vitro. Endocrinology 137: 2457–2463, 1996
31. 31 Jowsey J, Raisz LG: Experimental osteoporosis and parathyroid activity. Endocrinology 82: 384–396, 1968
32. 32 Kim KJ, Itoh T, Tanahashi M, Kumegawa M: Activation of osteoclast‐mediated bone resorption by the supernatant from a rabbit synovial cell line in response to polyethylene particles. J Biomed Mater Res 32: 3–9, 1996
33. 33 Kimble RB, Matayoshi AB, Vannice JL. Kung VT, Williams C, Pacifici R: Simultaneous block of interleukin‐1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 136: 3054–3061, 1995
34. 34 Klaushofer K, Horandner H, Hoffmann O, Czerweuka E, Konig U, Koller K, Peterlik M: Interferon gamma and calcitonin induce differential changes in cellular kinetics and morphology of osteoclasts in cultured neonatal mouse calvaria. J Bone Miner Res 4: 585–606, 1989
35. 35 Lacey DL, Erdmann JM, Shima, M., Kling, S, Matayoshi, A, Ohara J, Perkins SL: Interleukin 4 enhances osteoblast macrophage colony‐stimulating factor, but not interleukin‐6, production. Calcif Tissue Int 55: 21–28, 1994
36. 36 Laccy DL, Erdmann JM, Teitelbaum SL, Tan HL, Ohara J, Shioi A: Interleukin 4, interferon‐gamma, and prostaglandin E impact the osteoclastic cell‐forming potential of murine bone marrow macrophages. Endocrinology 136: 2367–2376, 1995
37. 37 Laccy DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N., Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ: Osteoprotegrin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165–176, 1998
38. 38 Lowik C, Van der pluijm G, Bloys H, Hoekman K, Bijvoet O, Aarden L, Papapoulos S: Parathyroid hormone (PTH) and PTH‐like protein (PLP) stimulate interleukin‐6 production by osteogenic cells: a possible role of interleukin‐6 in osteoclastogenesis. Biochem Biophys Res Commun 162: 1546–1552, 1989
39. 39 Maloney WJ, Smith RL: Periprosthetic osteolysis in total hip arthroplasty: the role of particulate wear debris. J Bone Joint Surg [Am] 77: 1448–1461, 1995
40. 40 Manolagas SC, Jilka RL: Bone marrow, cytokines, and bone remodeling: emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332: 305–311, 1995
41. 41 Merkel KD, Teitelbaum SL, Ross FP, Erdmann JM: Polymethylmethacrylate induced osteolysis is mediated by the p55 TNF receptor in vivo. Trans Orthop Res Soc 23: 126, 1998
42. 42 Miyaura C, Kusano K, Masuzawa T, Chaki O, Onoe Y, Aoyagi M, Sasaki T, Tamura T, Koishihara Y, Ohsugi Y, Suda T: Endogenous bone‐resorbing factors in estrogen deficiency: co‐operative effects of IL‐1 and IL‐6. J Bone Miner Res 10: 1365–1373, 1995
43. 43 Most W, Van beek E, Ruwhof C, Van bezooijen R, Ederveen A, Kopf M, Papapoulos S, Lowik C: Osteoclastic resorption in interleukin‐6 deficient mice. J Bone Miner Res 9 (Suppl 1): 132, 1994
44. 44 Murray DW, Rushton N: Macrophages stimulate bone resorption when they phagocytose particles. J Bone Joint Surg [Br] 72: 988–992, 1990
45. 45 Nagasaki K, Yamaguchi K, Watanabe K, Eto S, Abe K: Interleukin‐4 blocks parathyroid hormone‐related protein‐induced hypercalcemia in vivo. Biochem Biophys Res Commun 178: 694–698, 1991
46. 46 Ninomiya JT, Struve JA, Greenfield EM: Interleukin‐4 induces the expression and synthesis of the bone resorbing cytokines IL‐6 and LIF in osteoblasts. J Bone Miner Res 11 (Suppl 1): 169, 1996
47. 47 Onoe Y, Miyaura C, Kaminakayashiki T, Nagai Y, Noguchi K, Chen QR, Seo H, Ohta H, Nozawa S, Kudo I, Suda T: IL‐13 and IL‐4 inhibit bone resorption by suppressing cyclooxygenase‐2‐dependent prostaglandin synthesis in osteoblasts. J Immunol 156: 758–764, 1996
48. 48 Owens JM, Gallagher AC, Chambers TJ: IL‐10 modulates formation of osteoclasts in murine hemopoietic cultures. J Immunol 157: 936–940, 1996
49. 49 Pacifici R, Vannice JL, Rifas L, Kimble RB: Monocytic secretion of interleukin‐1 receptor antagonist in normal and osteoporotic women: effects of menopause and estrogen/progesterone therapy. J Clin Endocrinol Metab 77: 1135–1141, 1993
50. 50 Partridge NC, Alcorn D, Michelangeli VP, Ryan G, Martin TJ: Morphological and biochemical characterization of four clonal osteogenic sarcoma cell lines of rat origin. Cancer Res 43: 4308–4314, 1983
51. 51 Passeri G, Girasole G, Jilka RL, Manolagas SC: Increased interleukin‐6 production by murine bone marrow and bone cells after estrogen withdrawal. Endocrinology 133: 822–828, 1993
52. 52 Pilbeam C, Rao Y, Alander C, Voznesensky O, Okada Y, Sims J., Raisz L, Lorenzo J: Downregulation of mRNA expression for the “decoy” interleukin‐1 receptor 2 by ovariectomy in mice. J Bone Miner Res 12 (Suppl 1): 433, 1997
53. 53 Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto G, Rodan GA, Costantini F: Interleukin‐6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 13: 1189–1196, 1994
54. 54 Pollice P, Hicks DG, Rosier RN, Hsu J, Bukata S, Stroyer BF, Reynolds PR, Puzas JE, O'Keefe RJ: Identification and characterization of an operant anti‐inflammatory mechanism for the control of wear debris osteolysis. Trans Orthop Res Soc 22: 728, 1997
55. 55 Porteu F, Nathan C: Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med 172: 599–607, 1990
56. 56 Raisz LG: Stimulation of bone resorption by parathyroid hormone in tissue culture. Nature 197: 1015–1016, 1963
57. 57 Rodan GA, Raisz LG, Bilezikian JP: Pathophysiology of osteoporosis. In: Principles of Bone Biology, pp 979–990. Ed by JP Bilezikian LG Raisz and GA Rodan San Diego, Academic Press, 1996
58. 58 Roodman GD: Interleukin‐6: an osteotropic factor? J Bone Miner Res 7: 475–478, 1992
59. 59. Sato M, Grasser W: Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy. J Bone Miner Res 5: 31–40, 1990
60. 60 Seckinger P, Klein‐Nulend J, Alander C, Thompson RC, Dayer JM, Raisz LG: Natural and recombinant human IL‐1 receptor antagonists block the effects of IL‐1 on bone resorption and prostaglandin production. J Immunol 145: 4181–4184, 1990
61. 61 Shibutan T, Heersche JN: Effect of medium pH on osteoclast activity and osteoclast formation in cultures of dispersed rabbit osteoclasts. J Bone Miner Res 8: 331–336, 1993
62. 62 Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R., Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, Derose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw‐Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Boyle WJ, Sander S, Van G, Tarpley J, Derby P, Lee R, Amgen, EST Program, Boyle WJ: Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89: 309–319, 1997
63. 63 Soliman DM, Twigg HL 3rd: Cigarette smoking decreases bioactive interleukin‐6 secretion by alveolar macrophages. Am J Physiol 263: L471–L478, 1992
64. 64 Stashenko P, Wang CY, Tani‐Ishii N, Yu SM: Pathogenesis of induced rat periapical lesions. Oral Surg Oral Med Oral Pathol 78: 494–502, 1994
65. 65 Suda T, Takahashi N, Martin TJ: Modulation of osteoclast differentiation. Endocr Rev 13: 66–80, 1992
66. 66 Suda T, Takahashi N, Martin TJ: Modulation of osteoclast differentiation: update 1995. In: Hormonal Regulation of Bone Mineral Metabolism. pp 266–270. Ed by DD Bikle and A Negro‐vilar Bethesda. Endocrine Society Press, 1995
67. 67 Sunyer T, Lewis J, Osdoby P: Estrogen decreases the steady state levels of the IL‐1 signaling receptor (type I) while increasing those of the IL‐1 decoy receptor (type II) mRNAs in human osteoclast‐like cells. J Bone Miner Res 12 (Suppl 1): 135, 1997
68. 68 Taichman RS, Reilly MJ, Verma RS, Emerson SG: Augmented production of interleukin‐6 by normal human osteoblasts in response to CD34+ hematopoietic bone marrow cells in vitro. Blood 89: 1165–1172, 1997
69. 69 Tsurukami H, Nakamura T, Yamaura M, Narusawa K, Ohnishi H, Kanou A, Suzuki K: Thyroparathyroidectomy (TPTX) prevents the immobilization osteopenia by reducing the increase of osteoclasts in immobilized bone. Calcif Tissue Int 50 (Suppl 1): A42, 1992
70. 70 Twigg HL 3rd, Wilkes DS, Soliman DM: Measurement of IL‐6 inhibitory activity in cultured cell supernatants and lysates. J Lab Clin Med 124: 283–292, 1994
71. 71 Udagawa N, Horwood NJ, Elliott J, Mackay A, Owens J, Okamura H, Kurimoto M, Chambers TJ, Martin TJ, Gillespie MT: Interleukin‐18 (interferon‐gamma‐inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony‐stimulating factor and not via interferon‐gamma to inhibit osteoclast formation. J Exp Med 185: 1005–1012, 1997
72. 72 Vaes G: Cellular biology and biochemical mechanism of bone resorption: a review of recent developments on the formation, activation, and mode of action of osteoclasts. Clin Orthop 231: 239–271, 1988
73. 73 Wahl SM, Costa GL, Corcoran M, Wahl LM, Berger AE: Transforming growth factor‐beta mediates IL‐1‐dependent induction of IL‐1 receptor antagonist. J Immunol 150: 3553–3560, 1993
74. 74 Watanabe K, Tanaka Y, Morimoto I, Yahata K, Zeki K, Fujihira T, Yamashita U, Eto S: Interleukin‐4 as a potent inhibitor of bone resorption. Biochem Biophys Res Commun 172: 1035–1041, 1990
75. 75 Weir EC, Lowik CW, Paliwal I, Insogna KL: Colony stimulating factor‐1 plays a role in osteoclast formation and function in bone resorption induced by parathyroid hormone and parathyroid hormone‐related protein. J Bone Miner Res 11: 1474–1481, 1996
76. 76 Weyand CM, Geisler A, Brack A, Bolander ME, Goronzy JJ: Oligoclonal T‐cell proliferation and interferon‐gamma production in periprosthetic inflammation. Lab Invest 78: 677–685, 1998
77. 77 Wooley PH, Sud S, Robbins PD, Whalen JD, Evans CH, Nasser S: Contrasting effects of gene therapy to inhibit interleukin‐1β or tumor necrosis factor alpha in the murine inflammatory response to wear particles. Trans Orthop Res Soc 23: 122, 1998
78. 78 Yasuda H, Shima N, Nakagawa N, Mochizuki SI, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, Kanno T, Murakami A, Tsuda E, Morinaga T, Higashio K: Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139: 1329–1337, 1998